US Stock MarketDetailed Quotes

EXAS Exact Sciences

Watchlist
  • 54.720
  • -16.790-23.48%
Close Nov 6 16:00 ET
  • 54.510
  • -0.210-0.38%
Post 20:02 ET
10.13BMarket Cap-47172P/E (TTM)

Exact Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
469.43%138.72M
6.61%107.07M
-115.39%-82.31M
169.83%156.12M
33.65%69.55M
159.52%24.36M
264.86%100.42M
78.01%-38.22M
-118.67%-223.56M
311.77%52.04M
Net income from continuing operations
-4,915.62%-38.24M
80.49%-15.81M
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
Operating gains losses
-88.10%657K
-767.26%-11.56M
133.06%2.42M
-141.18%-14.42M
-221.98%-14.36M
--5.52M
--1.73M
-2,378.82%-7.32M
218.93%35.02M
9,170.87%11.77M
Depreciation and amortization
4.82%54.77M
5.07%53M
8.44%53.94M
4.58%206.61M
9.48%54.17M
7.59%52.25M
-2.74%50.44M
4.40%49.74M
9.54%197.56M
9.65%49.48M
Deferred tax
58.15%-398K
172.67%428K
42.51%1.8M
91.98%-955K
73.54%-676K
78.42%-951K
80.55%-589K
165.95%1.26M
95.30%-11.9M
42.62%-2.56M
Other non cash items
114.23%10.04M
-198.27%-12.95M
11,245.76%13.15M
-264.90%-62.55M
-173.49%-5.05M
-1,410.76%-70.56M
211.81%13.17M
99.33%-118K
-108.36%-17.14M
49.84%6.87M
Change In working capital
280.80%44.43M
-46.26%29.24M
-90.36%-108.21M
98.70%-342K
-61.01%26.66M
-24.83%-24.57M
5,610.18%54.42M
25.21%-56.84M
-123.74%-26.38M
-27.17%68.36M
-Change in receivables
97.43%-509K
-572.78%-23.37M
-47.58%-37.54M
-171.07%-43.42M
-109.39%-3.11M
-643.77%-19.81M
-74.80%4.94M
-330.80%-25.43M
142.89%61.09M
-15.48%33.12M
-Change in inventory
-1,670.17%-9.61M
117.32%1.16M
81.72%-1.07M
41.88%-7.69M
252.69%5.38M
-214.80%-543K
-202.80%-6.7M
26.83%-5.83M
-43.49%-13.23M
56.63%-3.53M
-Change in payables and accrued expense
2,308.71%56.12M
-33.45%35.65M
-1,010.96%-53.52M
258.59%82.75M
-14.62%31.67M
123.47%2.33M
503.06%53.57M
92.71%-4.82M
-130.73%-52.18M
-64.83%37.09M
-Change in other current assets
-38.72%3.64M
132.74%9.31M
51.65%-6.59M
-13,730.95%-11.62M
-264.67%-7.93M
907.89%5.94M
62.98%4M
-105.80%-13.62M
---84K
--4.82M
-Change in other current liabilities
58.23%-5.21M
567.31%6.49M
-33.10%-9.51M
7.29%-20.37M
120.59%647K
-82.79%-12.48M
75.23%-1.39M
-11.75%-7.14M
-31.68%-21.97M
35.23%-3.14M
Cash from discontinued investing activities
Operating cash flow
469.43%138.72M
6.61%107.07M
-115.39%-82.31M
169.83%156.12M
33.65%69.55M
159.52%24.36M
264.86%100.42M
78.01%-38.22M
-118.67%-223.56M
311.77%52.04M
Investing cash flow
Cash flow from continuing investing activities
-147.86%-81.72M
-321.33%-147.13M
-306.70%-171.44M
-32.93%49.68M
-14.80%-66.77M
-150.72%-32.97M
206.91%66.47M
82.04%82.94M
106.84%74.07M
-174.15%-58.16M
Net PPE purchase and sale
-3.86%-26.16M
-3.30%-35.87M
-28.23%-37.65M
42.09%-124.19M
52.08%-34.92M
43.57%-25.19M
45.17%-34.72M
12.68%-29.36M
-57.96%-214.46M
-22.70%-72.88M
Net business purchase and sale
----
----
46.38%-237K
-19.94%-68.98M
39.50%-18.98M
----
----
62.29%-442K
88.89%-57.51M
64.63%-31.37M
Net investment purchase and sale
-125.11%-10.54M
-210.12%-111.5M
-218.28%-133.35M
-24.41%243.1M
-127.62%-12.87M
-50.51%41.97M
-7.82%101.25M
40.29%112.74M
186.98%321.59M
-79.48%46.58M
Net other investing changes
-18,108.00%-45.02M
--0
---205K
-101.02%-250K
--0
-99.00%250K
----
----
141.57%24.45M
0.00%-500K
Cash from discontinued investing activities
Investing cash flow
-147.86%-81.72M
-321.33%-147.13M
-306.70%-171.44M
-32.93%49.68M
-14.80%-66.77M
-150.72%-32.97M
206.91%66.47M
82.04%82.94M
106.84%74.07M
-174.15%-58.16M
Financing cash flow
Cash flow from continuing financing activities
-345.65%-226K
1,300.18%224.6M
-102.25%-3M
108.89%159.77M
-0.65%10.04M
-60.85%92K
-74.70%16.04M
4,784.68%133.6M
802.80%76.49M
182.84%10.1M
Net issuance payments of debt
--0
--216.75M
--0
175.95%137.98M
--0
--0
--0
--137.98M
310.54%50M
--0
Proceeds from stock option exercised by employees
97.96%2.13M
13.08%19.45M
-246.06%-1.41M
-1.48%31.54M
16.96%12.3M
14.45%1.08M
5.68%17.2M
-77.49%964K
-14.64%32.02M
-13.04%10.52M
Net other financing activities
-139.39%-2.36M
-903.64%-11.59M
70.17%-1.59M
-76.33%-9.75M
-443.65%-2.27M
-39.52%-985K
59.62%-1.16M
-245.44%-5.34M
-4.62%-5.53M
23.35%-417K
Cash from discontinued financing activities
Financing cash flow
-345.65%-226K
1,300.18%224.6M
-102.25%-3M
108.89%159.77M
-0.65%10.04M
-60.85%92K
-74.70%16.04M
4,784.68%133.6M
802.80%76.49M
182.84%10.1M
Net cash flow
Beginning cash position
-11.35%536.02M
-16.57%351.78M
151.11%609.68M
-23.11%242.79M
152.50%594.91M
182.92%604.66M
121.84%421.66M
-23.11%242.79M
-78.83%315.77M
-14.04%235.6M
Current changes in cash
766.71%56.78M
0.87%184.54M
-243.98%-256.75M
600.72%365.56M
222.00%12.82M
-135.03%-8.52M
657.35%182.94M
242.14%178.32M
93.79%-73.01M
-90.45%3.98M
Effect of exchange rate changes
251.66%1.87M
-618.64%-306K
-307.27%-1.14M
4,303.33%1.32M
-39.27%1.95M
49.16%-1.24M
111.57%59K
332.07%550K
30.43%30K
13,839.13%3.21M
End cash Position
-0.04%594.67M
-11.35%536.02M
-16.57%351.78M
151.11%609.68M
151.11%609.68M
152.50%594.91M
182.92%604.66M
121.84%421.66M
-23.11%242.79M
-23.11%242.79M
Free cash flow
13,727.24%112.56M
8.36%71.2M
-77.52%-119.96M
107.29%31.93M
266.16%34.63M
99.03%-826K
152.88%65.7M
67.41%-67.58M
-84.04%-438.02M
75.18%-20.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 469.43%138.72M 6.61%107.07M -115.39%-82.31M 169.83%156.12M 33.65%69.55M 159.52%24.36M 264.86%100.42M 78.01%-38.22M -118.67%-223.56M 311.77%52.04M
Net income from continuing operations -4,915.62%-38.24M 80.49%-15.81M -48.65%-110.23M 67.26%-204.15M 61.04%-49.77M 100.53%794K 51.21%-81.03M 59.02%-74.15M -4.68%-623.51M 42.09%-127.75M
Operating gains losses -88.10%657K -767.26%-11.56M 133.06%2.42M -141.18%-14.42M -221.98%-14.36M --5.52M --1.73M -2,378.82%-7.32M 218.93%35.02M 9,170.87%11.77M
Depreciation and amortization 4.82%54.77M 5.07%53M 8.44%53.94M 4.58%206.61M 9.48%54.17M 7.59%52.25M -2.74%50.44M 4.40%49.74M 9.54%197.56M 9.65%49.48M
Deferred tax 58.15%-398K 172.67%428K 42.51%1.8M 91.98%-955K 73.54%-676K 78.42%-951K 80.55%-589K 165.95%1.26M 95.30%-11.9M 42.62%-2.56M
Other non cash items 114.23%10.04M -198.27%-12.95M 11,245.76%13.15M -264.90%-62.55M -173.49%-5.05M -1,410.76%-70.56M 211.81%13.17M 99.33%-118K -108.36%-17.14M 49.84%6.87M
Change In working capital 280.80%44.43M -46.26%29.24M -90.36%-108.21M 98.70%-342K -61.01%26.66M -24.83%-24.57M 5,610.18%54.42M 25.21%-56.84M -123.74%-26.38M -27.17%68.36M
-Change in receivables 97.43%-509K -572.78%-23.37M -47.58%-37.54M -171.07%-43.42M -109.39%-3.11M -643.77%-19.81M -74.80%4.94M -330.80%-25.43M 142.89%61.09M -15.48%33.12M
-Change in inventory -1,670.17%-9.61M 117.32%1.16M 81.72%-1.07M 41.88%-7.69M 252.69%5.38M -214.80%-543K -202.80%-6.7M 26.83%-5.83M -43.49%-13.23M 56.63%-3.53M
-Change in payables and accrued expense 2,308.71%56.12M -33.45%35.65M -1,010.96%-53.52M 258.59%82.75M -14.62%31.67M 123.47%2.33M 503.06%53.57M 92.71%-4.82M -130.73%-52.18M -64.83%37.09M
-Change in other current assets -38.72%3.64M 132.74%9.31M 51.65%-6.59M -13,730.95%-11.62M -264.67%-7.93M 907.89%5.94M 62.98%4M -105.80%-13.62M ---84K --4.82M
-Change in other current liabilities 58.23%-5.21M 567.31%6.49M -33.10%-9.51M 7.29%-20.37M 120.59%647K -82.79%-12.48M 75.23%-1.39M -11.75%-7.14M -31.68%-21.97M 35.23%-3.14M
Cash from discontinued investing activities
Operating cash flow 469.43%138.72M 6.61%107.07M -115.39%-82.31M 169.83%156.12M 33.65%69.55M 159.52%24.36M 264.86%100.42M 78.01%-38.22M -118.67%-223.56M 311.77%52.04M
Investing cash flow
Cash flow from continuing investing activities -147.86%-81.72M -321.33%-147.13M -306.70%-171.44M -32.93%49.68M -14.80%-66.77M -150.72%-32.97M 206.91%66.47M 82.04%82.94M 106.84%74.07M -174.15%-58.16M
Net PPE purchase and sale -3.86%-26.16M -3.30%-35.87M -28.23%-37.65M 42.09%-124.19M 52.08%-34.92M 43.57%-25.19M 45.17%-34.72M 12.68%-29.36M -57.96%-214.46M -22.70%-72.88M
Net business purchase and sale ---- ---- 46.38%-237K -19.94%-68.98M 39.50%-18.98M ---- ---- 62.29%-442K 88.89%-57.51M 64.63%-31.37M
Net investment purchase and sale -125.11%-10.54M -210.12%-111.5M -218.28%-133.35M -24.41%243.1M -127.62%-12.87M -50.51%41.97M -7.82%101.25M 40.29%112.74M 186.98%321.59M -79.48%46.58M
Net other investing changes -18,108.00%-45.02M --0 ---205K -101.02%-250K --0 -99.00%250K ---- ---- 141.57%24.45M 0.00%-500K
Cash from discontinued investing activities
Investing cash flow -147.86%-81.72M -321.33%-147.13M -306.70%-171.44M -32.93%49.68M -14.80%-66.77M -150.72%-32.97M 206.91%66.47M 82.04%82.94M 106.84%74.07M -174.15%-58.16M
Financing cash flow
Cash flow from continuing financing activities -345.65%-226K 1,300.18%224.6M -102.25%-3M 108.89%159.77M -0.65%10.04M -60.85%92K -74.70%16.04M 4,784.68%133.6M 802.80%76.49M 182.84%10.1M
Net issuance payments of debt --0 --216.75M --0 175.95%137.98M --0 --0 --0 --137.98M 310.54%50M --0
Proceeds from stock option exercised by employees 97.96%2.13M 13.08%19.45M -246.06%-1.41M -1.48%31.54M 16.96%12.3M 14.45%1.08M 5.68%17.2M -77.49%964K -14.64%32.02M -13.04%10.52M
Net other financing activities -139.39%-2.36M -903.64%-11.59M 70.17%-1.59M -76.33%-9.75M -443.65%-2.27M -39.52%-985K 59.62%-1.16M -245.44%-5.34M -4.62%-5.53M 23.35%-417K
Cash from discontinued financing activities
Financing cash flow -345.65%-226K 1,300.18%224.6M -102.25%-3M 108.89%159.77M -0.65%10.04M -60.85%92K -74.70%16.04M 4,784.68%133.6M 802.80%76.49M 182.84%10.1M
Net cash flow
Beginning cash position -11.35%536.02M -16.57%351.78M 151.11%609.68M -23.11%242.79M 152.50%594.91M 182.92%604.66M 121.84%421.66M -23.11%242.79M -78.83%315.77M -14.04%235.6M
Current changes in cash 766.71%56.78M 0.87%184.54M -243.98%-256.75M 600.72%365.56M 222.00%12.82M -135.03%-8.52M 657.35%182.94M 242.14%178.32M 93.79%-73.01M -90.45%3.98M
Effect of exchange rate changes 251.66%1.87M -618.64%-306K -307.27%-1.14M 4,303.33%1.32M -39.27%1.95M 49.16%-1.24M 111.57%59K 332.07%550K 30.43%30K 13,839.13%3.21M
End cash Position -0.04%594.67M -11.35%536.02M -16.57%351.78M 151.11%609.68M 151.11%609.68M 152.50%594.91M 182.92%604.66M 121.84%421.66M -23.11%242.79M -23.11%242.79M
Free cash flow 13,727.24%112.56M 8.36%71.2M -77.52%-119.96M 107.29%31.93M 266.16%34.63M 99.03%-826K 152.88%65.7M 67.41%-67.58M -84.04%-438.02M 75.18%-20.84M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Cancer Research
Cancer Research
Intraday-1.53%